Search alternatives:
larger decrease » marked decrease (Expand Search)
small decrease » small increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a larger » a large (Expand Search), _ larger (Expand Search), _ large (Expand Search)
larger decrease » marked decrease (Expand Search)
small decrease » small increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a larger » a large (Expand Search), _ larger (Expand Search), _ large (Expand Search)
-
1
-
2
Biases in larger populations.
Published 2025“…<p>(<b>A</b>) Maximum absolute bias vs the number of neurons in the population for the Bayesian decoder. …”
-
3
-
4
-
5
-
6
-
7
The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER.
Published 2025“…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”
-
8
BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers.
Published 2024“…<p>(<b>A)</b> Changes in TEER with increasing culture time on days 1–22. (<b>B)</b> BA alleviated the LPS-induced decrease in TEER in Caco2 cells after treatment for 24 h. …”
-
9
-
10
-
11
-
12
-
13
Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers.
Published 2024“…<p>(<b>A)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on days 1–22. (<b>B)</b> Y-27632 collaborated with BA to attenuate the effect of LPS on TEER in Caco2 cells on day 22. …”
-
14
-
15
-
16
-
17
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
18
The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness.
Published 2025“…Parameter values: interaction strengths were drawn from a half-normal distribution of zero mean and a standard deviation of 0.2, and strength for consumers was made no larger than the strength for resources. …”
-
19
-
20